Literature DB >> 10226904

Reversible catecholamine-induced cardiomyopathy in a heart transplant candidate without persistent or paroxysmal hypertension.

E S Brilakis1, W F Young, J W Wilson, G B Thompson, T M Munger.   

Abstract

BACKGROUND: Both dilated and hypertrophic cardiomyopathy have been reported in patients with pheochromocytoma, who were almost always hypertensive. The outcome frequently has been fatal, yet cardiac dysfunction can be reversible after medical or surgical therapy for the pheochromocytoma.
METHODS: We report the case of a patient with dilated cardiomyopathy without persistent or paroxysmal hypertension, who was found to have a pheochromocytoma during initial medical evaluation.
RESULTS: The identification and treatment of the pheochromocytoma led to significant improvement in cardiac function and cardiac transplantation was avoided.
CONCLUSIONS: This case illustrates some unusual features in pheochromocytoma-induced cardiomyopathy: (1) absence of persistent or paroxysmal hypertension, (2) initial presentation with acute myocardial infarction and normal coronary arteries, and (3) recurrent episodes of nonsustained ventricular tachycardia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226904     DOI: 10.1016/s1053-2498(98)00014-x

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  7 in total

Review 1.  Pheochromocytoma as an endocrine emergency.

Authors:  Frederieke M Brouwers; Jacques W M Lenders; Graeme Eisenhofer; Karel Pacak
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  Pheochromocytoma, a rare cause of acute cardiogenic shock.

Authors:  Ole Eschen; Ole Frøbert; Vibeke Jensen; Steen Hvitfeldt Poulsen
Journal:  Clin Res Cardiol       Date:  2007-03-21       Impact factor: 5.460

3.  Hypertension in pheochromocytoma: characteristics and treatment.

Authors:  Samuel M Zuber; Vitaly Kantorovich; Karel Pacak
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

Review 4.  Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.

Authors:  B Maisch; S Pankuweit
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

Review 5.  Catecholamine-Induced Cardiomyopathy in Pheochromocytoma: How to Manage a Rare Complication in a Rare Disease?

Authors:  Jenn Rachelle U Santos; Alessandra Brofferio; Bruna Viana; Karel Pacak
Journal:  Horm Metab Res       Date:  2018-09-18       Impact factor: 2.936

6.  Catecholamines Induce Left Ventricular Subclinical Systolic Dysfunction: A Speckle-Tracking Echocardiography Study.

Authors:  Jan Kvasnička; Tomáš Zelinka; Ondřej Petrák; Ján Rosa; Branislav Štrauch; Zuzana Krátká; Tomáš Indra; Alice Markvartová; Jiří Widimský; Robert Holaj
Journal:  Cancers (Basel)       Date:  2019-03-06       Impact factor: 6.639

7.  Clinical features, complications, and outcomes of exogenous and endogenous catecholamine-triggered Takotsubo syndrome: A systematic review and meta-analysis of 156 published cases.

Authors:  Shams Y-Hassan; Henrik Falhammar
Journal:  Clin Cardiol       Date:  2020-03-03       Impact factor: 2.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.